• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, November 10, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Caregivers face strain when patients receive heart pumps

Bioengineer by Bioengineer
March 7, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

DALLAS, March 7, 2018 – When heart failure patients receive a heart pumping device known as a left ventricular assist device (LVAD), their caregivers seem to suffer, too – at least initially, according to research in Journal of the American Heart Association (JAHA), the Open Access Journal of the American Heart Association/American Stroke Association.

In a study of 50 pairs of heart failure patients and their caregivers, researchers noted that patients reported dramatically improved quality of life in the first month after receiving an LVAD, however at the same time, caregivers reported significantly increased strain – a subjective measure of stress related to caregiving.

The American Heart Associations' scientific statement on LVAD patient selection notes that adequate social support is crucial for the success of LVAD therapy, and many centers require patients to have a designated primary caregiver (i.e., unpaid family member or friend) to help them manage their condition.

Researchers found caregiver strain worsens immediately after implant and then returns to pre-implant levels over six months, but does not further improve. The quality of the patient-caregiver relationship was associated with better outcomes for both, and may be a target for future interventions.

The greatest sources of strain for LVAD caregivers in this sample were time constraints (no time for self-care or other obligations) and compromised social life, followed by physical strain.

The study is one of the first to examine how the patient-caregiver relationship may influence both patient and caregiver outcomes.

"As cardiologists using heart pumps to support this extremely sick group of heart failure patients, we sometimes neglect the impact of our therapies on caregivers and families. This clearly shows how these advanced therapies affect caregivers, and that the relationship of the patients to their caregivers can alter outcomes," said JAHA Editor in chief Barry London, M.D., Ph.D., who is also Director of Cardiovascular Medicine at the University of Iowa Carver College of Medicine.

Researchers say interdisciplinary clinical approaches that consider both the patient and the

caregiver as individuals as well as the characteristics and health of their relationship to one another may be more effective than solely patient-focused approaches.

###

The lead author is Julie T. Bidwell, Ph.D., R.N., Emory University Nell Hodgson Woodruff School of Nursing, in Atlanta, Georgia. Author disclosures and funding information is on the manuscript.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at http://www.heart.org/corporatefunding.

About the American Heart Association

The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation's oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.

Media Contact

Bridgette McNeill
[email protected]
214-706-1135
@HeartNews

http://www.heart.org

https://newsroom.heart.org/news/caregivers-face-strain-when-patients-receive-heart-pumps?preview=19c309135af359344543967b257ef214

Related Journal Article

http://dx.doi.org/10.1161/JAHA.117.008080

Share12Tweet7Share2ShareShareShare1

Related Posts

Houston Medical Tech Firm Takes Top Prize at Scientific Sessions 2025 Global Health Tech Competition

November 10, 2025

Revolutionary SynNotch Receptor Detects Amyloid Beta Aggregates

November 10, 2025

Micro-rubbing Boosts Sperm Fertilization Efficiency in ICSI

November 10, 2025

Unveiling Losartan’s Uncommon Side Effect: Angioedema

November 10, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    316 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    208 shares
    Share 83 Tweet 52
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    139 shares
    Share 56 Tweet 35
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1304 shares
    Share 521 Tweet 326

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tailored Cultivar Responses to Highland Potato Late Blight

Decoding Cold Sensitivity in Mussaenda anomala

Margot and Tom Pritzker Prize for AI in Scientific Research Unveils Winners at Conference

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.